ENXTAM:DSFIRChemicals
DSM Firmenich (ENXTAM:DSFIR) EPS Rebound To €1.94 Tests Long Term Bearish Narratives
DSM-Firmenich (ENXTAM:DSFIR) has reported first half FY 2025 revenue of €6.5b and basic EPS of €1.94, setting a clear benchmark for investors assessing how the business is currently running. Over the last three reported half years, revenue has moved from €6.3b in H1 2024 to €6.5b in H2 2024 and €6.5b in H1 2025, while basic EPS has shifted from €0.16 to €0.79 and then to €1.94, with trailing twelve month EPS at €2.72 on €13.0b of revenue. Taken together, these numbers indicate firmer...